Suppr超能文献

2 型糖尿病相关髋部骨折的差异死亡率和超额率:考虑到骨折预测中的竞争风险很重要。

Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters.

机构信息

Biostatisitcs Unit at Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.

Department of Basic Medical Sciences, Universitat de Barcelona, Barcelona, Spain.

出版信息

J Bone Miner Res. 2018 Aug;33(8):1417-1421. doi: 10.1002/jbmr.3435. Epub 2018 May 3.

Abstract

Type 2 diabetes (T2DM) is associated with a reduced life expectancy. The latest published evidence suggests an increased risk of fractures among T2DM patients. We conducted a population-based cohort study to determine the impact of mortality as a competing risk in the study of the association between T2DM and hip fracture rates. Participants were all diagnosed T2DM patients registered in the Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) database aged 65 years and older; up to two non-T2DM were matched by age, sex, and primary care facility. We used Cox regression models to estimate cause-specific hazard ratio (HR) of death or hip fracture according to T2DM status. Fine and Gray models were then fitted to estimate the subhazard ratio (SHR) of hip fracture while accounting for competing risk with death and to estimate the probability of hip fracture within 5 years. A total of 55,891 T2DM and 103,093 matched non-T2DM patients were observed for a median of 8 years. Mortality was 48.8 per 1000 person years (py) in T2DM, and 33.8 per 1000 py in non-T2DM; hip fracture rates were 6.0 per 1000 py and 4.9 per 1000 py, respectively. Cox models confirmed a significant association for death and hip fracture: HR 1.51 (95% CI, 1.48 to 1.55), and HR 1.32 (95% CI, 1.24 to 1.40), respectively. Accounting for death as a competing event (Fine-Gray models), the association between T2DM and hip fracture risk remained statistically significant (SHR 1.15; 95% CI, 1.09 to 1.21) and the probability of a hip fracture within 5 years was 2.3% for TD2M and 1.9% for non-TD2M patients compared to 2.6% and 2.1% respectively using Kaplan-Meier (KM) estimates. T2DM patients have a 50% increased mortality and, after adjusting for differential survival at 5 years, a 21% increased incidence of hip fracture when compared to matched non-T2DM. Failing to account for differential mortality leads to an overestimation of fracture risk. © 2018 American Society for Bone and Mineral Research.

摘要

2 型糖尿病(T2DM)与预期寿命缩短有关。最新发表的证据表明,T2DM 患者骨折风险增加。我们进行了一项基于人群的队列研究,以确定在研究 T2DM 与髋部骨折发生率的关系时,死亡率作为竞争风险的影响。参与者均为年龄在 65 岁及以上的登记在 Sistema de Información para el Desarrollo de la Investigación en Atención Primaria(SIDIAP)数据库中的 T2DM 患者;按年龄、性别和初级保健机构匹配了最多两名非 T2DM 患者。我们使用 Cox 回归模型根据 T2DM 状况估计死亡或髋部骨折的特定原因风险比(HR)。然后拟合 Fine 和 Gray 模型以估计在考虑死亡竞争风险的情况下髋部骨折的亚风险比(SHR),并估计 5 年内髋部骨折的概率。共观察了 55891 名 T2DM 和 103093 名匹配的非 T2DM 患者,中位随访时间为 8 年。T2DM 患者的死亡率为每 1000 人年 48.8 人(py),而非 T2DM 患者的死亡率为每 1000 py 33.8 人;髋部骨折发生率分别为每 1000 py 6.0 和 4.9。Cox 模型证实死亡和髋部骨折存在显著相关性:HR 1.51(95%CI,1.48 至 1.55)和 HR 1.32(95%CI,1.24 至 1.40)。考虑到死亡作为竞争事件(Fine-Gray 模型),T2DM 与髋部骨折风险之间的关联仍然具有统计学意义(SHR 1.15;95%CI,1.09 至 1.21),与 Kaplan-Meier(KM)估计值相比,5 年内髋部骨折的概率为 T2DM 患者 2.3%,非 T2DM 患者 1.9%,而分别为 2.6%和 2.1%。与匹配的非 T2DM 患者相比,T2DM 患者的死亡率增加了 50%,并且在调整 5 年时的生存差异后,髋部骨折的发生率增加了 21%。如果不考虑死亡率的差异,会导致骨折风险的高估。© 2018 美国骨骼与矿物质研究协会。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验